Hu Zhou
- Cancer Research top 0.5%
- Molecular Biology top 1%
- Metabolomics and Mass Spectrometry Studies 19
- Ubiquitin and proteasome pathways 18
- RNA modifications and cancer 15
- Glycosylation and Glycoproteins Research 11
- Spectroscopy top 1%
- Advanced Proteomics Techniques and Applications 36
- Mass Spectrometry Techniques and Applications 27
- Oncology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 13
-
- Liver Disease Diagnosis and Treatment 12
- Journals
- Nature (1 paper)Science (1 paper)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Hu Zhou
199 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1.8k
- Molecular Biology 5.1k
- Spectroscopy 921
- Pulmonary and Respiratory Medicine 946
- Oncology 736
Countries citing papers authored by Hu Zhou
This map shows the geographic impact of Hu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Zhou more than expected).
Fields of papers citing papers by Hu Zhou
This network shows the impact of papers produced by Hu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Zhou. The network helps show where Hu Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hu Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 24 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 12 | |
| 11 | 2022 | 41 | |
| 12 | 2021 | 9 | |
| 13 | Long Noncoding RNA EBLN3P Promotes the Progression of Liver Cancer via Alteration of microRNA-144-3p/DOCK4 Signal | 2020 | 3 |
| 14 | 2019 | 24 | |
| 15 | 2019 | 54 | |
| 16 | Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNAbreakdown → | 2019 | 429 |
| 17 | A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53breakdown → | 2018 | 402 |
| 18 | 2018 | 18 | |
| 19 | 2018 | 68 | |
| 20 | 2016 | 32 |
About Hu Zhou
Hu Zhou is a scholar working on Spectroscopy, Molecular Biology and Cancer Research, having authored 212 papers that have together received 7.0k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (36 papers), Mass Spectrometry Techniques and Applications (27 papers), Metabolomics and Mass Spectrometry Studies (19 papers), Ubiquitin and proteasome pathways (18 papers), RNA modifications and cancer (15 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Liver Disease Diagnosis and Treatment (12 papers) and Glycosylation and Glycoproteins Research (11 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (5.1k citations) and Spectroscopy (921 citations). Hu Zhou has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Daniel Figeys, Rong Zeng, Hualiang Jiang, Cheng Luo, Desheng Xiao, Weiwei Lai, Yongguang Tao, Ya Cao, Yating Liu and Chao Mao. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.